Pathways' Pick of the Week: Africa Centralizes Medtech Regulations

article image
ARTICLE SUMMARY:

The African Medicines Agency launches. Excerpted from Pathways’ Picks May 28: Global Picks, FDA Guidance Docs, MDUFA Support, and More.

Africa is on the cusp of fully launching its continent-wide agency for centralizing and harmonizing oversight of drugs, vaccines, and medical devices. Even as the top-down structure of the African Medicines Agency (AMA) is still being put into place, there is already an infrastructure established to initiate medtech regulatory efforts. This foundation helped keep track of availability and performance of IVDs for COVID-19, and now it is stepping up to serve a more direct premarket review function for the continent in response to the Mpox (or monkeypox) outbreak in a growing number of African countries. (For more on AMA and medtech harmonization efforts in Africa, see in Market Pathways, Charting a Continent’s Course: Africa’s Push Toward Harmonized Medical Device Regulation.”)

Continue reading Pathways’ Picks here.
×



Articles from David Filmore:

Regulatory & Reimbursement

Tariff Topsy-Turvy, CPT Panel Decisions, Reliance in South Africa

In this week’s Pathways Picks: The US Supreme Court struck down President Trump’s tariffs, but Trump immediately moved to reboot the levies; no medtech in SOTU; CPT panel approves new codes including AI; FDA updates MDUFA stats and taps new digital health director; South Africa outlines its global regulatory reliance policies for devices; and more global updates.

Read Article